You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

LOVASTATIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lovastatin patents expire, and when can generic versions of Lovastatin launch?

Lovastatin is a drug marketed by Actavis Elizabeth, Aurobindo Pharma Usa, Carlsbad, Chartwell Rx, Corepharma, Epic Pharma Llc, Lupin, Sun Pharm Industries, and Teva. and is included in ten NDAs.

The generic ingredient in LOVASTATIN is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lovastatin

A generic version of LOVASTATIN was approved as lovastatin by ACTAVIS ELIZABETH on December 17th, 2001.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LOVASTATIN?
  • What are the global sales for LOVASTATIN?
  • What is Average Wholesale Price for LOVASTATIN?
Drug patent expirations by year for LOVASTATIN
Drug Prices for LOVASTATIN

See drug prices for LOVASTATIN

Drug Sales Revenue Trends for LOVASTATIN

See drug sales revenues for LOVASTATIN

Recent Clinical Trials for LOVASTATIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityN/A
Heart Health Research CenterPhase 4
AstraZenecaPhase 4

See all LOVASTATIN clinical trials

Pharmacology for LOVASTATIN
Medical Subject Heading (MeSH) Categories for LOVASTATIN

US Patents and Regulatory Information for LOVASTATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva LOVASTATIN lovastatin TABLET;ORAL 075551-003 Dec 17, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva LOVASTATIN lovastatin TABLET;ORAL 075551-002 Dec 17, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Actavis Elizabeth LOVASTATIN lovastatin TABLET;ORAL 075828-001 Dec 17, 2001 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Corepharma LOVASTATIN lovastatin TABLET;ORAL 077748-003 Feb 28, 2007 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lupin LOVASTATIN lovastatin TABLET;ORAL 078296-003 Nov 1, 2007 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Usa LOVASTATIN lovastatin TABLET;ORAL 075935-002 Dec 17, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma Usa LOVASTATIN lovastatin TABLET;ORAL 075451-001 Dec 17, 2001 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.